Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Aug 24;4(5):e393.
doi: 10.1212/NXI.0000000000000393. eCollection 2017 Sep.

Understanding anti-IgLON5 disease

Francesc Graus  1 , Joan Santamaría  1
Affiliations
Editorial

Understanding anti-IgLON5 disease

Francesc Graus et al. Neurol Neuroimmunol Neuroinflamm. .
No abstract available

PubMed Disclaimer

References

    1. Dalmau J, Geis C, Graus F. Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev 2017;97:839–887. - PMC - PubMed
    1. Tan A, Shuey N, Bladin C. A modern perspective on the differential diagnosis between encephalitis lethargica or anti-NMDA-receptor encephalitis. J Clin Neurosci 2010;17:1204–1206. - PubMed
    1. Sabater L, Gaig C, Gelpi E, et al. . A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 2014;13:575–586. - PMC - PubMed
    1. Gelpi E, Höftberger R, Graus F, et al. . Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol 2016;132:531–543. - PMC - PubMed
    1. Gaig C, Graus F, Compta Y, et al. . Clinical manifestations of the anti-IgLON5 disease. Neurology 2017;88:1736–1743. - PMC - PubMed

Publication types

LinkOut - more resources